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1146-37 Prognostic Impact of No ST Segment Elevation 
Resolution in Acute Myocardial Infarction Complicated 
by Cardiogenic Shock 
Francoise Boutot, Jean Marie Caussanel, Francois Gandon, Stephane Hazan, Jean 
Marc Boyer, Yves Lambert, Samu 78 Versailles Hospital, Le Chesnay, France. 
Background : ST segment resolution (RST), during fibrinolysis therapy (FT) for acute 
myocardial infarction (AMI), is a good marker of myocardial reperfusion. The in-hospital 
mortality increases with time to reperfusion when cardiogenic shock (CS) complicates 
AMI. 
Objectives: The aim of this study is to assess the no-RST during prehospital fibrinolysis 
for ST segment elevation myocardial infarction (STEMI) complicated by CS as an early 
predictor of mortality for triage. 
Method : In a cohort of 643 patients, receiving prehospital FT for STEMI (pain to FT, 
mean time 120mn), 39 patients had STEMI complicated by CS. ECG was performed 
prior starting the FT, baseline ECG, and on ICU admission, admission ECG (FT to ICU, 
mean time 55mn).Two classes of RST were defined : no resolution (RST < 30%), partial 
or complete resolution (RST >30%).ICU mortality was investigated for each class of RST 
within 30 days. 
Results : Results are shown in the table below. No-RST on admission ECG is signifi- 
cantly (p<0.05) correlated to a higher ICU mortality rate when STEMI is complicated by 
CS. 
Conclusion : No-RST, during the first hour of FT for STEMI complicated by CS, predicts 
no myocardial reperfusion and high risk of ICU death within 30 days. This clinical marker 
is easy to perform at bedside, and should participate to an early scoring system for deci- 
sion making. 
STEMI patients CS patients STEMI mortality(%) CS mortality (%) 
No-RST 231 22 20 (5.7%) 9 (40.9%) 
Partial or Complete RST 412 17 21 (5.1%) 0 (0%) 
Total 643 39 41 (6.4 %) 9 (23.1%) 
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1147-38 Passive Ventricular Restraint With Nitinol Mesh 
Attenuates Remodeling Following Acute Myocardial 
Infarction 
Leah A. TeekelI-Tavlor. Sunil Mankad, Uday Dasika, Walter E. McGregor, Robert W. W. 
Biederman, June Yamrozik, Dennis R. Trumble, James A. Magovern, Allegheny Genera/ 
Hospital, Pittsburgh, Pennsylvania. 
Background: Cardiac failure can occur after a large myocardial infarction due to left ven- 
tricular remodeling. This study examines the effects of a novel compliant ventricular 
restraint device placed in sheep after anterior transmural infarction. 
Methods: The device under study is a custom-shaped nitinol mesh designed to fit over 
both ventricles and exert a restraining force when stretched (Paracor, Inc.) Fourteen 
adult female sheep were studied, with half serving as controls. Cardiac MRI scans and 
hemodynamic measurements were completed before and six weeks after infarction from 
ligation of the anterior descending and second diagonal coronary arteries. Treatment ani- 
mals received passive ventricular restraint concurrently with LV infarction, all devices 
being implanted through a left thoracotomy and sutured to the AV groove. Differences 
between groups were detected using unpaired t-tests. Data are presented as mean + 
SD. 
Results: Left ventricular dilatation and hypertrophy were significantly reduced in the pas- 
sive restraint group relative to control, increases in LV end-diastolic volume index were 
reduced by a factor of four with application of the device, (0.83 + 0.50 vs 0.20 ± 0.41 m!.J 
kg, p < .03). Likewise, end-systolic volumes of mesh heads increased only half as much 
as controls (0.90 + 0.38 vs 0.43 ± 0.28 mL/kg, p < .03). LV mass index increased by 7% 
in control animals following infarction in contrast to a 13% decrease in the device group 
(0.14 + 0.19 vs -0.25 + 0.36 g/kg, p < .03). LV dp/dt was higher in the device group after 
infarction (1304 ± 213 vs 1002 -+ 118 mmHg/s, p < .05), and mean arterial pressures 
tended to be higher (89 ± 17 vs 69 ± 13, p = .09). When compared to normal baseline, no 
significant change in LV or PA end diastolic pressures was detected with the device. No 
gross or microscopic evidence of epicardial injury was found. 
Conclusion: Nitinol mesh attenuated remodeling and improved LV function following 
acute myocardial infarction in sheep without evidence of restriction or injury to epicardial 
structures. 
1147-39 Low Mortality in Ischemic Cardiomyopathy Treated With 
Coronary Artery Bypass Grafting Despite Negative 
Viabi l i ty  Study 
Umesh N. Khot, M. Luav Alkotob. Ahmed Abdel Latif, Richard C. Brunken, Patrick M. 
McCarthy, Nicholas G. Smedira, Randall C. Starling, The Cleveland Clinic Foundation, 
Cleveland, Ohio. 
Background: Coronary revascularization is often used to treat patients with ischemic 
cardiomyopathy. However, patients with ischemic cardiomyopathy and negative myocar- 
dial viability studies have been increasingly managed medically because of doubts 
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regarding the benefits of revascularization in this population. 
Methods: We reviewed all patients from 1995 to 1999 with ejection fraction _< 0.35 who 
underwent PET rest and stress (IV dipyridimole) testing with rubidium-82 and lSFDG 
prior to a decision regarding revascularization. Patients with severe coronary artery dis- 
ease but negative viability studies (scar only, no ischemia or hibernation) who subse- 
quently underwent CABG were analyzed. Patients who underwent CABG and 
concomitant valvular surgery were excluded. 
Results: Ten patients (7 Males, 3 Females) with a mean age of 68 ± 6 years and mean 
ejection fraction of 0.24 + 0.05 were analyzed. During a mean followup of 36 _+ 18 months 
(range 15 to 70 months), survival was 90%. 
Conclusion: In an elderly population with severe left ventricular dysfunction, coronary 
artery bypass grafting despite a negative viability study is associated with a very low mor- 
tality over a three year followup period. A randomized trial is needed to study this strat- 
egy directly against medical therapy. 
1147-40 Nonlnvasive Assessment of Internal Thoracic Artery  
Graft  Patancy  by Evaluat ing Left  Anterior Descending 
Flow With a New Transthoracic Ultrasound Technology 
Masao Yoshitatsu, Yuji Miyamoto, Koichi Toda, Shinya Fukui, Kenji Onishi, Division of 
Cardiovascular Surgery, Sakurabashi-Watanabe hospital, Osaka, Japan. 
Background: Transthorecic echocardiography (TTE) is a standard method to evaluate 
the wall motion in patients (pts) undergoing coronary artery bypass grafting(CABG). 
However, it has not been established to examine the bypass graft. The aim of this study 
is to evaluate a new TTE method which examines the graft patency by measuring the for- 
ward flow of the left anterior descending coronary artery(LAD) before and after the 
CABG. Methods: Fifty-nine pts (66±8 years) undergoing CABG between August 2000 
and August 2001 were studied. The grafts anastomosed to LAD were left ITA in 50 pts, 
right ITA in 9 pts. Before CABG, Doppler velocity profiles of distal LAD were recorded 
with transthorecic Doppler echocardiography (SONOS 5500;Hewlett Packard, and 12- 
MHz sector probe). The diameters of LAD(cm), total velocity time integrals (V'l'l)(cm), 
systolic VTI and diastolic VTI, and heart rates(bpm) were measured. LAD forward flow 
(mVmin) was obtained from the product of velocity time integral multiplied by the cross- 
sectional area of LAD and heart rate. The diastolic-to-systolic VTI ratios were calculated. 
Three weeks after CABG, LAD forward flow in the distal portion of the anastomosis was 
obtained by the same method. This flow included the native flow and the bypass flow. 
Simultaneously the graft patency was evaluated by the angiography. Results: Overall 
success rate of measuring the LAD flow by this method was 69% preoperatively and 
88% postoperatively. In 19 pts, in which all parameters were obtained both pre- and post- 
operatively, LAD forward flow increased significantly from 21.8±21.2 mVmin to 40.9±22.1 
mVmin (p<0.0001) and the diastolic-to-systolic VTP ratios also increased significantly from 
3.33±1.62 to 5.30±2.92 after CABG (p<0.03). These results indicated the significant 
increase in the LAD flow during diastolic phase. Postoperative angiography showed 
excellent patency at the anastomosis site in all pts. This result correlated with those of 
TTE. Conclusion: This new "l-rE method can evaluate LAD flow easily before and after 
the CABG and may provide noninvasive and useful information about the graft patency. 
1147-41 The Effect o f  Nonfata l  Perioperative Cardiac Events on 
Long-Term Mortality or Cardiac Readmission 
Steve K. Sinoh. Kathy Sykora, Jack V. Tu, C. D. Naylor, Christopher M Feindel, Samuel 
V. Lichtenstein, Stephen E. Fremes, Sunnybrook and Women's College Health Sciences 
Center, Toronto, Ontario, Canada, The Institute for Clinical Evaluative Sciences, Toronto, 
Ontario, Canada. 
Background: The purpose of this study was to determine the effects of non-fatal periop- 
erative cardiac events (low output syndrome [LOS] and myocardial infarction by Q-wave 
[ECG-MI] or enzyme criteria [CKMB-MI]) on late survival or event-free survival after coro- 
nary artery bypass graft surgery (CABG). Methods: The Warm Heart Trial data was 
merged with administrative databases containing survival and hospital readmission infor- 
mation. Results: Follow-up was achieved for 94% (1,635) of the original subjects. At 101 
months late survival was less in patients with, versus those without, a non-fatal perioper- 
ative event (79.7 +/- 2.8% vs. 86.1 +/- 1.1%, p<0.0001). Predictors of late mortality by 
Cox proportional hazards models were renal insufficiency, left ventricular dysfunction, 
older age, diabetes and redo CABG. Use of the left internal thoracic artery was protec- 
tive. Events that were associated independently with reduced late survival were CKMB- 
MI (adjusted relative risk 2.1, 95% confidence interval 1.5-2.9, p<0.0001) and LOS 
(adjusted relative risk 1.6, 95% confidence interval 1.0-2.3, p=0.04). Event-free survival 
was less in patients who had a non-fatal perioperative event (62.6 +/- 1.6% vs. 55.0 +/- 
3.5%, p<0.0001). Risk factors for event-free survival were those for mortality alone, plus 
urgent surgery and female gender. Non-fatal CKMB-MI had an independent adverse 
effect on late results (adjusted relative risk 1.7, 95% confidence intewal 1.4-2.1, 
p<0.0001). Cardioplegia type did not affect early, late or event-free survival. Conclu- 
sions: Non-fatal perioperative cardiac events were associated with reduced survival and 
event-free survival after CABG surgery. LOS and CKMB-MI had a greater impact than 
ECG-MI. 
1147-42 Min imal ly  Invasive Surgical Treatment of Atrial 
Fibrillation Using Bipolar Radiofrequency on the 
Beating Heart 
Sunil M. Prasad. Hersh S. Maniar, Michael Diodato, Rick Schuessler, Ralph J. Damiano, 
Jr., Washington University School of Medicine, St. Louis, Missouri. 
INTRODUCTION: Current transvenous and epicardial treatments of atria] fibrillation (AF) 
using unipolar radiofrequency (RF) catheters have had poor results primarily due to their 
inability to consistently produce transmural lesions. These catheters lack any feedback 
regarding lesion transmurality, which may lead to multiple applications, extended ablation 
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times and high tissue temperatures, resulting in unnecessary collateral tissue injury. This 
study tested the ability of bipolar RF energy to create transmural lesions on the beating 
heart that would permanently isolate atrial myocardium. 
METHODS: Baseline pacing on 6 dogs was performed on the following target areas: 
right and left atdal appendage, superior and inferior vena cavae, and right and left pulmo- 
nary veins. A cuff of atrial myocardium, proximal to the target tissue was clamped 
between the two arms of the bipolar device to produce continuous circumferential linear 
lesions from the epicardium. RF energy (86 Watts) was delivered until tissue cooduc- 
tanca between the electrodes fell to a stable minimal level of 0.0025 Mhos. Following 
ablation, pacing documented acute isolation. Animals were survived for 30 days and per- 
manent isolation was evaluated by pacing studies utilizing a 256-channel atrial mapping 
system. Histology was evaluated by H&E and Trichrome stain. 
RESULTS: 34 lesions were made at the initial surgery. Mean ablation time was 4.9 = 1.6 
seconds and mean peak tissue temperature was 46.6 = 3.0 °C. All lesions (34/34) 
acutely and permanently isolated atrial tissue. Mapping studies with pacing of atrial tis- 
sue on both sides of the lesion confirmed isolation. Histology demonstrated that all 
lesions were linear, continuous, and transmural with no thrombus formation or stenosis. 
The average maximum width for all lesions was 1.9 ± 0.7 mm (range 1.0 to 3.0). Lesions 
were produced up to a length of 50 mm and a depth of 8 mm. 
CONCLUSION: Bipolar RF energy rapidly produced permanent ransmural linear lesions 
on the beating heart with a single application. Real time measurement of tissue conduc- 
tance reliably predicted lesion transmurality. This new technology should enable a cura- 
tive minimally invasive operation for AF on the beating heart. 
1147-43 Does Off  Pump Coronary Artery Bypass Graft Surgery 
Reduce Poet-Operative Right Ventriculer Dysfunction? 
Balvinder S. Wasan. Niket Patal, Rex Stanbitdge, Brian Glenville, Simon Thorn, Rodney 
A. Foale, Jamil Mayer, Imperial College and St Mary's Hospital, London, United 
Kingdom. 
Background: Coronary artery bypass grafting (CABG) on the beating heart without car- 
dio-pulmonary bypass ('off pump') has gained increasing popularity. Numerous advan- 
tages over on-pump surgery, including improved post-operative ventricular function, have 
been cited. We compared the effect on postoperative ventricular function of the 2 meth- 
ods using tissue Doppler echocardiography (TDE). This technique allows the objective 
and non-invasive measurement of regional myocardial velocities. Methods: 20 patients 
with 3-vessel coronary artery disease undergoing elective CABG were included. 10 had 
on-pump and 10 had off-pump procedures. Each had pulsed wave TDE images obtained 
from the apex, providing visualisetion of the tricuspid free wall annulus and 4 regions of 
the mitral valve annulus. Systolic and diastolic velocities were compared immediately 
before and 5 days after surgery. Results: Both groups were comparable in terms of 
demographics and disease severity. All subjects had a left internal mammary artery graft 
with a mean of 2.5 vein grafts to the other vessels. All had a graft to the right coronary 
system. Compared to baseline, both on and off-pump groups showed a marked 
decrease in the right ventricular (RV) peak systolic and diastolic velocities (Table). While 
the reduction in velocities was less in the off-pump group, the difference between the two 
groups failed to reach statistical significance. Conclusions: There is significant RV dys- 
function after CABG with both on and off-pump techniques. 
Mean Change In Peak Velocity (cm/s) (*p<0.01 from baseline) 
RV Systolic RV Diastolic LV Systolic LV Diastolic 
Off-pump -6.5±1.2" -5.0=0.8" 0.4=0.4 0.8=0.7 
On-pump -5.2±1.3" -3.9=0.8* 0.4=0.6 0.9=0.8 
1147-44 Late Follow-Up of the Warm Heart Trial: Eight-Year 
Results 
Steve K. Sinah, Kathy Sykora, Jack V. Tu, C. D. Naylor, Christopher M. Feindel, Samuel 
V. Lichtenstein, Stephen E. Frames, Sunnybrook and Women's College Health Sciences 
Center, Toronto, Ontario, Canada, The Institute for Clinical Evaluative Sciences, Toronto, 
Ontario, Canada. 
Background: The Warm Heart Trial randomized 1,732 patients undergoing coronary 
artery bypass graft surgery to warm or cold blood cardioplegia. Warm patients had signif- 
icantly less non-fatal perioperative cardiac events and 30-day mortality was non-signifi- 
cantly decreased (1.4% vs. 2.5%, p=0.12). The purpose of this study was to evaluate the 
long-term outcomes of these patients to determine if different techniques for myocardial 
protection affect survival or hospital readmission for non-fatal, late cardiac events. Meth- 
ods: Late outcomes were obtained by merging clinical trial and population-based, admin- 
istrative databases. Results: Long-term outcomes were determined for 96% of the 
original patients. Median follow-up was 85 +/- 20 months for mortality, and 81 +/- 32 
months for mortality or hospital reedmission. Maximum follow-up was 101 months. Base- 
line clinical, angiographic and operative characteristics were similar between the Warm 
and Cold groups. Late survival was non-significantly greater in the Warm group (84.7 +/- 
1.4% vs. 82.4 +/- 1.6%, p=0.30) with an adjusted relative risk of 0.861 in multivariate 
models (95% confidence interval 0.668-1.109, p=0.25). Freedom from mortality or hospi- 
tal readmission for non-fatal late cardiac events was also non-signiticantly greater with 
warm cardioplegia (61.8 +/- 2.0% vs. 58.7 +/- 2.2%, p=0.74). Hospitalization for non-fatal 
late cardiac events was similar between cardioplegia types. Conclusions: Despite 
improved perioperative outcomes with warm cardioplegia, analysis of late outcomes did 
not demonstrate any substantial advantage over conventional methods of myocardial 
protection. 
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851-1 Effect of the Angiotensin II Type I Receptor Blocker 
Candesartan on Cardiovascular Events 
Junichiro Kondo, Takahito Sone, Hideyuki Tsuboi, Hiroaki Mukawa, Itsuro Modshima, 
Michitaka Uesugi, Takashi Kosaka, Tomohiro Yoshida, Ogaki Municipal Hospital, Ogaki, 
Japan. 
Background: Angiotensin II may play an important role in the pathogenesis of coronary 
artery disease. We assessed the effect of the angiotensin II receptor blocker candesertan 
in patients at high risk for cardiovascular events. Methods: A total of 406 patients were 
randomly and prospectively assigned to a candesartan group (4 mg/day) or a control 
group. All patients had a history of coronary intervention, and had no significant coronary 
stanosis on follow-up angiography 6 months after intervention. The primary endpoint was 
a composite of revasculaffzation, nonfatal myocardial infarction, or death from cardiovas- 
cular causes. The secondary endpoint was hospitalization due to cardiovascular causes 
(worsening angina or heart failure). Results: There were no differences between the two 
groups in clinical characteristics. Discontinuation of drug administration was required for 
only 9 patients, due to hypotansioo or dizziness. Neither the blood pressure at baseline 
nor that at follow-up differed between the groups. There were 62 cardiac events over a 
mean foUow-up period of 24 months. Treatment with csndesertan reduced primary end- 
point risk (6.2%, compared with 12.3% in the control group; relative risk, 0.49; 95 % con- 
fidence interval, 0.25 to 0.98; P=0.04) (revascularization occurred in 8 cases in the 
candesartan group and 15 cases in the control group, nonfatal myocardial infarction in 2 
and 1 cases, and death in 2 and 9 cases, respectively). The frequencies of secondary 
endpoints did not differ significant between the two groups (worsening angina occurred in 
9 cases in the candesertan group and 14 cases in the control group, and heart failure in 
0 and 2 cases, respectively). The frequencies of all cardiac events were significantly 
lower in the candesertan group (10.8%) than in the control group (20.2%, P=0.03). Con- 
clusion: Candesartan was beneficial for preventing cardiovascular events in high-risk 
patients. 
10:45 a.m. 
851-2 Detecting Myocardial lechemle From Four Bipolar 
Leads Reconstructed From the Unipoles That Are 
Potentially Available in Implanted Devices 
Azad Ghuran. Dan Wichtede, lan Little, Kamran Baig, Velislav Batchvarov, A John 
Camm, Charles Pumphrey, David Ward, Marek Malik, Cardiological Sciences, St. 
George's Hospital Medical School London, United Kingdom. 
Background: The technology to detect myocardial ischaemia using right-sided cardiac 
electrodes can be useful in implanted devices, such as cardiac pacemakers and implant- 
able cardioverters defibrillators. This study investigated the diagnostic accuracy of moni- 
toring myocardial ischaemia from intracardiac recordings during elective percutaneous 
coronary angioplasty. 
Method: Forty-eight patients were investigated with a total of 194 balloon inflations (23 
left anterior descending, 2 diagonals, 8 circumflex, 5 obtuse marginals and 23 right coro- 
nary arteries). Standard 12-lead ECGs were compared with reconstructed bipolar record- 
ings: pectoral-right ventricle (PEC-RV), superior vena cava and RV (SVC-RV), right 
atdum-RV (RA-RV) and coronary sinus-RV (CS-RV). 
Results: The graph below displays median of ST segment deviation from baseline in the 
respective leads during the first 30 seconds of balloon inflation, for all arteries. Compared 
to the best surface lead from the 12-lead ECG (V2), the bipolar leads were superior in 
detecting ischaemic ST changes (p<0.0001, Wilcoxon matched pairs test). 
Conclusion: Monitoring regional myocardial ischaemia, irrespective of the epicardial 
artery involved from right-sided intracardiac electrodes is feasible, and may be incorpo- 
rated into the algorithms of implanted devices to improve their diagnostic and therapeutic 
strategies. 
